Cysticercosis is an endemic disease in many developing countries. This diagnosis is based on the cystic aspect of the lesions, particularly in case of stay in endemic areas and serology. The clinical manifestations are of very variable expression and go from the completely asymptomatic form to very severe tables putting at stake the vital prognosis of the patient. We report in this article the case of a 43-year-old woman who was admitted to the neuropsychiatric center Dr. Joseph Guislain of ‘’Brothers of Charity’’ in Lubumbashi/DRC for a neurocysticercosis revealed by a behavioral disorder and generalized tonic clonic seizures. She was treated with albendazole 15 mg/kg/day/15 days, phenobarbital 100 mg/day at 20 h, haldol 5 mg/day/10 days and prednisolone 1 mg/kg/day/15 days. Its evolution was marked by a clear improvement of its clinical condition under treatment.
